ProQR Therapeutics N.V.
USD1.86
+0.04 (+1.91%)
CEO
Daniel Anton de Boer
IPO Date
2014-09-18
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
NL
Open
$1.84
Prev. Close
$1.83
Day Low
$1.80
Day High
$1.87
52W Low
$1.33
52W High
$3.10
Market Cap
$0.20B
Volume
0.21M
| -7.5 |
| 31 Dec 2023 | FY | 100.0% | -431.7% | -61.5% | -18.5% | 0.48 | 3.54 | -5.2 |
| 31 Dec 2022 | FY | 100.0% | -1792.5% | -96.1% | -37.6% | 0.33 | 7.36 | -3.8 |
| 31 Dec 2021 | FY | 100.0% | -4549.8% | -53.4% | -29.0% | 0.53 | 6.94 | -7.4 |
| 31 Dec 2020 | FY | 100.0% | -4525.3% | -66.7% | -38.5% | 0.60 | 7.77 | -3.7 |
| 31 Dec 2019 | FY | -5943.6% | -2935.6% | -53.6% | -43.0% | 0.14 | 10.43 | -6.4 |
| 31 Dec 2018 | FY | 80.1% | -746.7% | -39.7% | -33.5% | 0.10 | 13.28 | -12.7 |
| 31 Dec 2017 | FY | 165.5% | 2854.0% | -110.9% | -82.2% | 0.18 | 5.95 | -1.6 |
| 31 Dec 2016 | FY | 43.8% | -1713.5% | -73.6% | -59.7% | 0.11 | 9.24 | -2.8 |
| -5.0 |
| 30 Sept 2025 | Q3 | 100.0% | -377.6% | -19.3% | -8.9% | 0.29 | 3.36 | -4.3 |
| 30 Jun 2025 | Q2 | 100.0% | -319.1% | -18.2% | -8.9% | 0.25 | 3.76 | -3.7 |
| 31 Mar 2025 | Q1 | 100.0% | -223.0% | -11.8% | -6.2% | 0.19 | 4.10 | -3.2 |
| 31 Dec 2024 | Q4 | 100.0% | -216.0% | -10.5% | -5.5% | 0.19 | 3.95 | -5.6 |
| 30 Sept 2024 | Q3 | 100.0% | -211.0% | -32.5% | -7.6% | 0.70 | 2.33 | -4.1 |
| 30 Jun 2024 | Q2 | 100.0% | -42.7% | -8.2% | -2.3% | 0.58 | 2.73 | -11.7 |
| 31 Mar 2024 | Q1 | 100.0% | -172.1% | -20.4% | -5.7% | 0.51 | 3.11 | -5.4 |
| 31 Dec 2023 | Q4 | 100.0% | -167.0% | -12.0% | -3.6% | 0.48 | 3.54 | -6.4 |